663 related articles for article (PubMed ID: 12023620)
1. Long-term islet graft survival in streptozotocin- and autoimmune-induced diabetes models by immunosuppressive and potential insulinotropic agent FTY720.
Fu F; Hu S; Deleo J; Li S; Hopf C; Hoover J; Wang S; Brinkmann V; Lake P; Shi VC
Transplantation; 2002 May; 73(9):1425-30. PubMed ID: 12023620
[TBL] [Abstract][Full Text] [Related]
2. Triptolide prolonged allogeneic islet graft survival in chemically induced and spontaneously diabetic mice without impairment of islet function.
Xin MJ; Cui SH; Liu S; Sun HC; Li F; Sun JB; Luo B
Hepatobiliary Pancreat Dis Int; 2010 Jun; 9(3):312-8. PubMed ID: 20525560
[TBL] [Abstract][Full Text] [Related]
3. FTY720, a novel immunosuppressive agent with insulinotropic activity, prolongs graft survival in a mouse islet transplantation model.
Fu F; Hu S; Li S; DeLeo J; Hoover J; Wang S; Lake P; Shi V
Transplant Proc; 2001; 33(1-2):672-3. PubMed ID: 11267010
[No Abstract] [Full Text] [Related]
4. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice.
Guo Z; Mital D; Shen J; Chong AS; Tian Y; Foster P; Sankary H; McChesney L; Jensik SC; Williams JW
Transplantation; 1998 May; 65(10):1310-4. PubMed ID: 9625011
[TBL] [Abstract][Full Text] [Related]
5. Prevention of autoimmune diabetes by FTY720 in nonobese diabetic mice.
Maki T; Gottschalk R; Monaco AP
Transplantation; 2002 Dec; 74(12):1684-6. PubMed ID: 12499880
[TBL] [Abstract][Full Text] [Related]
6. The immune modulator FYT720 prevents autoimmune diabetes in nonobese diabetic mice.
Yang Z; Chen M; Fialkow LB; Ellett JD; Wu R; Brinkmann V; Nadler JL; Lynch KR
Clin Immunol; 2003 Apr; 107(1):30-5. PubMed ID: 12738247
[TBL] [Abstract][Full Text] [Related]
7. Islet allograft survival in nonhuman primates immunosuppressed with basiliximab, RAD, and FTY720.
Wijkstrom M; Kenyon NS; Kirchhof N; Kenyon NM; Mullon C; Lake P; Cottens S; Ricordi C; Hering BJ
Transplantation; 2004 Mar; 77(6):827-35. PubMed ID: 15077021
[TBL] [Abstract][Full Text] [Related]
8. Long-term effect of FTY720 on lymphocyte count and islet allograft survival in mice.
Liu L; Wang C; He X; Shang W; Bi Y; Wang D
Microsurgery; 2007; 27(4):300-4. PubMed ID: 17477424
[TBL] [Abstract][Full Text] [Related]
9. BCG immunotherapy prevents recurrence of diabetes in islet grafts transplanted into spontaneously diabetic NOD mice.
Lakey JR; Singh B; Warnock GL; Rajotte RV
Transplantation; 1994 Apr; 57(8):1213-7. PubMed ID: 8178349
[TBL] [Abstract][Full Text] [Related]
10. Encapsulated piscine (tilapia) islets for diabetes therapy: studies in diabetic NOD and NOD-SCID mice.
Safley SA; Cui H; Cauffiel SM; Xu BY; Wright JR; Weber CJ
Xenotransplantation; 2014; 21(2):127-39. PubMed ID: 24635017
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune destruction of islet grafts in the NOD mouse is resistant to 15-deoxyspergualin but sensitive to anti-CD4 antibody.
Stegall MD; Loberman Z; Ostrowska A; Coulombe M; Gill RG
J Surg Res; 1996 Aug; 64(2):156-60. PubMed ID: 8812627
[TBL] [Abstract][Full Text] [Related]
12. The novel anti-inflammatory agent lisofylline prevents autoimmune diabetic recurrence after islet transplantation.
Yang Z; Chen M; Ellett JD; Fialkow LB; Carter JD; Nadler JL
Transplantation; 2004 Jan; 77(1):55-60. PubMed ID: 14724435
[TBL] [Abstract][Full Text] [Related]
13. Targeting lymphangiogenesis after islet transplantation prolongs islet allograft survival.
Yin N; Zhang N; Xu J; Shi Q; Ding Y; Bromberg JS
Transplantation; 2011 Jul; 92(1):25-30. PubMed ID: 21508896
[TBL] [Abstract][Full Text] [Related]
14. Human islet function is not impaired by the sphingosine-1-phosphate receptor modulator FTY720.
Truong W; Emamaullee JA; Merani S; Anderson CC; James Shapiro AM
Am J Transplant; 2007 Aug; 7(8):2031-8. PubMed ID: 17617868
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of thioredoxin in islets transduced by a lentiviral vector prolongs graft survival in autoimmune diabetic NOD mice.
Chou FC; Sytwu HK
J Biomed Sci; 2009 Aug; 16(1):71. PubMed ID: 19671194
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-4 or interleukin-10 expressed from adenovirus-transduced syngeneic islet grafts fails to prevent beta cell destruction in diabetic NOD mice.
Smith DK; Korbutt GS; Suarez-Pinzon WL; Kao D; Rajotte RV; Elliott JF
Transplantation; 1997 Oct; 64(7):1040-9. PubMed ID: 9381527
[TBL] [Abstract][Full Text] [Related]
17. Long-term insulin independence following repeated islet transplantation in totally pancreatectomized diabetic pigs.
Morsiani E; Fogli L; Lanza G; Lebow LT; Demetriou AA; Rozga J
Cell Transplant; 2002; 11(1):55-66. PubMed ID: 12095221
[TBL] [Abstract][Full Text] [Related]
18. Anti-TCR mAb induces peripheral tolerance to alloantigens and delays islet allograft rejection in autoimmune diabetic NOD mice.
Deng R; Khattar M; Xie A; Schroder PM; He X; Chen W; Stepkowski SM
Transplantation; 2014 Jun; 97(12):1216-24. PubMed ID: 24854475
[TBL] [Abstract][Full Text] [Related]
19. Agarose for a bioartificial pancreas.
Iwata H; Takagi T; Amemiya H; Shimizu H; Yamashita K; Kobayashi K; Akutsu T
J Biomed Mater Res; 1992 Jul; 26(7):967-77. PubMed ID: 1607377
[TBL] [Abstract][Full Text] [Related]
20. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
